← Back to Search

Behavioural Intervention

Healthy Minds Program for Depression (BeWell Trial)

N/A
Waitlist Available
Led By Richard Davidson
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Proficient in English
Able to provide informed consent
Must not have
Elevated PHQ-8 or PHQ-9 ≥ 5 at screening and pre-baseline interview
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1, week 2, week 3, week 4, and 3 month follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if the Healthy Minds Program app can help promote well-being in adults with depression symptoms.

Who is the study for?
This trial is for US adults who feel sad or can't enjoy daily activities, can consent to participate, speak English, and have a smartphone. It's not for those with a history of psychosis or mania or high depression scores (PHQ-8/9 ≥ 5).
What is being tested?
The study tests the Healthy Minds Program app against an active control without meditation and a waitlist group. The aim is to see if the app improves well-being in people with depression over four weeks.
What are the potential side effects?
Since this trial involves using an app designed for improving mental health, side effects may include discomfort from confronting personal issues during use but are generally expected to be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You must be able to speak and understand English well.
Select...
You understand the study and agree to participate in it.
Select...
You need to have a smartphone that can download apps from Google Play or the Apple App Store.
Select...
You must be either a citizen of the United States or have permanent residency in the United States in order to receive payment.
Select...
You have never experienced episodes of severe mental illness, such as psychosis or mania.
Select...
I feel sad and don't enjoy daily activities anymore.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
You have reported symptoms of depression with a score of 5 or higher on the PHQ-8 or PHQ-9 questionnaire.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1, week 2, week 3, week 4, and 3-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1, week 2, week 3, week 4, and 3-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Depression Symptoms Measured by Patient Health Questionnaire - 8 (PHQ-8) Score
Secondary study objectives
Change in Anxiety Symptoms Measured by Generalized Anxiety Disorder - 7 (GAD-7) Score
Change in Awareness Measured by Five Facet Mindfulness Questionnaire Acting with Awareness Subscale Score
Change in Climate Change Anxiety Scale
+16 more
Other study objectives
Change in Digital Working Alliance Inventory
Change in Facial Behavior
Change in Inclusion of Nature in Self
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Healthy Minds Program (HMP) appExperimental Treatment1 Intervention
Participants will receive access to the 4-week HMP Foundations module. The HMP app is a meditation-based smartphone app designed to promote and protect psychological well-being through sustainable skills training. The program is grounded in constituents of psychological well-being identified in empirical literature. HMP provides core content, with instruction administered through a curriculum of guided practices. HMP is based on research on eudaimonic well-being (e.g., environmental mastery, purpose) and brain-based skills that underlie these qualities (e.g., regulation of attention, mental flexibility). The full HMP has guided audio practices that address 4 constituents of well-being: awareness, connection, insight, and purpose. At post-treatment, participants will be given access to additional HMP content to support their continued practice.
Group II: Psychoeducation appActive Control1 Intervention
Participants will receive access to the 4-week HMP Foundations module with guided meditation practices removed. The active control will include only the didactic content included in HMP without the guided meditation practices.
Group III: Usual CareActive Control1 Intervention
Participants will receive access to HMP at the end of the study and will be encouraged to continue with their usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Healthy Minds Program
2022
N/A
~300

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,237 Previous Clinical Trials
3,199,899 Total Patients Enrolled
24 Trials studying Depression
9,496 Patients Enrolled for Depression
Hope for Depression Research FoundationOTHER
3 Previous Clinical Trials
345 Total Patients Enrolled
3 Trials studying Depression
345 Patients Enrolled for Depression
National Center for Complementary and Integrative Health (NCCIH)NIH
867 Previous Clinical Trials
673,871 Total Patients Enrolled
66 Trials studying Depression
32,470 Patients Enrolled for Depression
Richard DavidsonPrincipal InvestigatorUW-Madison, Center for Healthy Minds
Simon Goldberg, PhDPrincipal InvestigatorUW-Madison, Center for Healthy Minds
8 Previous Clinical Trials
6,727 Total Patients Enrolled
4 Trials studying Depression
965 Patients Enrolled for Depression

Media Library

Healthy Minds Program (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05183867 — N/A
Depression Research Study Groups: Healthy Minds Program (HMP) app, Psychoeducation app, Usual Care
Depression Clinical Trial 2023: Healthy Minds Program Highlights & Side Effects. Trial Name: NCT05183867 — N/A
Healthy Minds Program (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05183867 — N/A
Depression Patient Testimony for trial: Trial Name: NCT05183867 — N/A
~293 spots leftby Jan 2026